Difference between revisions of "TG002065"
Jump to navigation
Jump to search
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
|nrt=109.217 | |nrt=109.217 | ||
|ntransition=8 | |ntransition=8 | ||
| − | |pepnrt=use (- | + | |pepnrt=use (-1.994) |
|peptide=PE000265 | |peptide=PE000265 | ||
|prt=56.431 | |prt=56.431 | ||
Latest revision as of 15:48, 23 May 2021
| Peptide | R.N[H5N4S2]ISDGFDGIPDNVDAALALPAHSYSGR.E (PE000265) |
|---|---|
| Sequence | NISDGFDGIPDNVDAALALPAHSYSGR |
| Glycans(s) | H5N4S2 (N1) |
| Mod(s) | |
| Molecular Weight | 4,994.098 |
| Charge | 4+ |
| Protein | VTN (P04004) |
| Spectrum File | MS_35_Frac_plasma_run01_fr7_01 |
| Method | Orbitrap Fusion-Lumos, DDA (EThcD pd HCD), nano LC-MS/MS |
| Analytical Fraction | SAX-ERLICH Enrichment |
| Sample | Human Serum |
Transitions
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Prod. m/z | Prod. z | Label | %Int |
|---|---|---|---|---|---|---|---|---|
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 1,488.205 | 2+ | Y[pN] | 28.3 |
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 1,751.798 | 2+ | Y[pH2N2] | 20.9 |
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 1,832.824 | 2+ | Y[pH3N2] | 20.1 |
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 1,440.961 | 3+ | Y[pH4N3S] | 15.8 |
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 1,386.665 | 2+ | Y[p] | 10.0 |
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 1,289.912 | 3+ | Y[pH3N3] | 9.1 |
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 1,670.771 | 2+ | Y[pHN2] | 6.3 |
| 56.686 | 56.431 | 109.217 | 1,245.030 | 4+ | 992.473 | 3+ | Y[pN] | 6.1 |
Spectra
14091;EThcD;56.681;14085;1245.026;Byonic:q-value=3.07e-10/GPS:MinICScore=66.300
14093;HCD;56.686;14085;1245.026;